About

The British Phytomedicines Alliance was founded in May 2023 – established as the leading body representing the UK cannabis-based medicines industry.

Its founder members are: Glass Pharms, Celadon Pharmaceuticals and Phytome Life Sciences.

Our members are at the cutting-edge of phytomedicinal drug development, creating hundreds of high-quality jobs across the UK and raising many millions in investment to support the industry’s growth.

The BPA actively engages policy makers to ensure the value and full potential of this industry can be realised – and to deliver the best possible outcomes for patients.

With the right backing, BPA members can build a global success story for the British life sciences sector – and make a life-changing difference for millions of people currently suffering with chronic health conditions.

To find out more about how we can unlock the potential of this industry please click here.